{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-24-000015","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.397249+00:00","generated_at":"2026-06-03T00:49:38.109828+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sotera Health Q1 net rev up 12.5% to $248M; Adj EBITDA up 13.7%; reaffirms 2024 outlook","bullets":["Q1 net rev $248M (+12.5% YoY); net income $6M ($0.02 EPS) vs $3M ($0.01) YoY.","Adj EBITDA $112M (+13.7% YoY); Adj EPS $0.13 flat YoY.","Sterigenics segment net rev $166M (+4.1% YoY); segment income $86M (+3.6%).","Company reaffirms 2024 outlook amid market headwinds.","EPA finalized NESHAP update; Sterigenics expects to comply with emission control investments."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-24-000015","json":"https://secwatch.observer/filing/0001822479-24-000015.json","markdown":"https://secwatch.observer/filing/0001822479-24-000015.md","text":"https://secwatch.observer/filing/0001822479-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000015/0001822479-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000015/shc-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:49:38.109828+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c0461d212465925839b64128fa554259a4fd10d","claim":"Sotera Health Co reported three months ended March 31, 2024 results: revenue $248 million, net income $6 million, or $0.02 per diluted share, EPS $0.02 per diluted share. Guidance reaffirmed.","evidence_excerpt":"incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sotera Health Reports First-Quarter 2024 Results • Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023 • Q1 2024 net income of $6 million or $0.02 per diluted share, comp ared to net income of $3 million or $0.01 per diluted share in Q1 2023 • Q1 2024 Adjusted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822479/000182247924000015/0001822479-24-000015-index.htm","confidence":0.97,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"Revenue","value":"$248 million"},{"label":"Net income","value":"$6 million, or $0.02 per diluted share"},{"label":"EPS","value":"$0.02 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}